Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy

Head and Neck

Volumn 23, Issue 10, 2001, Pages 899-906

  Khurana, Dianne ^a   Martin, Elizabeth A ^b   Kasperbauer, Jan L ^a   O'Malley Jr , Bert W ^c   Salomao, Diva R ^a   Chen, Lieping ^b   Strome, Scott E ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer immunotherapy; Murine model; SCC VII

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; FEMALE; HEAD AND NECK CANCER; LUNG METASTASIS; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; HEAD AND NECK NEOPLASMS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, LYMPHOKINE-ACTIVATED; MICE; MICE, INBRED C3H; T-LYMPHOCYTES;

EID: 0034835565     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.1130     Document Type: Article

References (21)

1. Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the heal and neck established in nude mice
2. The role of chemotherapy in head and neck cancer
3. An orthotopic flor-of-mouth cancer model allows quantification of tumor: Invasion
4. Interleukini-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice
5. Immunology of head and neck cancer - Prospects for immunotherapy
6. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma
7. Immunology of head and neck cancer: Perspectives
8. Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2
9. Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma
10. Identification of NY-ESO-1, MAGE 1 and MAGE 3 tumor antigens in squamous cell carcinoma of the head and neck
11. Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
12. The effects of the human papilloma virus on patients with squamous cell cancer of the tonsil
13. Tumorlysate primed dendritic cells are effective vaccine against murine squamous cell carcinoma
14. Preclinical studies of dendritic cell-based vaccines for the treatment of squamous cell carcinoma
15. Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma
16. A new immunocompetent murine model for oral cancer
17. Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2
18. A murine model for the immunotherapy of head and neck squamous cell carcinoma
19. Secretion of both IL-2 and IL-4 by tumor cells results in rejection and immunity
20. Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes
21. Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma